MedTrace Logo

Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer

NCT00616590 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-06-17

No results posted yet for this study

Summary

RATIONALE: Learning about insomnia and quality of life in patients undergoing chemotherapy and radiation therapy for cancer may help doctors learn about the effects of treatment and plan the best treatment.

PURPOSE: This clinical trial is studying insomnia in patients undergoing chemotherapy and radiation therapy for head and neck cancer.

Conditions

Interventions

OTHER

medical chart review

OTHER

questionnaire administration

PROCEDURE

fatigue assessment and management

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Brittany Holmes · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616590 on ClinicalTrials.gov